MEDICAL RESEARCH AND YNHH
YNHH mandates its staff to wear masks

Since Jan. 15, Yale New Haven Hospital workers have been required to mask up when interacting with patients.

Former School of Medicine professor embroiled in artificial insemination lawsuit

Three mothers have sued Dr. Burton Caldwell for allegedly inseminating them with his own sperm without their consent. The University and Yale New Haven Hospital are co-defendants in one of the suits.

“This is about life and death”: Prospect hospitals will remain open, state officials promise

State officials reassure residents about continued care at the Prospect Medical Holdings’ Connecticut hospitals and announce planning accountability measures for financial mismanagement.

Prospect Medical Holdings files for bankruptcy, casting uncertainty over its Connecticut hospitals

Prospect listed over $400 million in debts but promised to keep its hospitals open.

Mind-altering remedies: inside the new wave of psychedelic research

A new effort into studying psychedelic substances for mental health treatment is getting attention from researchers at Yale and beyond.

YNHH doctors voice concerns over new physician compensation model

A shift to productivity-based pay sparks debate among YNHH physicians, highlighting fears of competition, inefficiencies and a potential loss of academic focus.

ANALYSIS: When private equity in healthcare goes wrong

Experts say private equity-run hospitals often leave patients behind. The News looked into private equity and its role in Yale New Haven Health’s acquisition deal with Prospect Medical Holdings.

Yale New Haven Hospital receives ‘C’ in hospital safety ratings

Based on a hospital review system by the Leapfrog Group, Yale New Haven Hospital and the Saint Raphael Campus performed worse than many other Connecticut hospitals in patient safety.

The teaching kitchen prescribes food instead of medicine

Yale spin-off company Modifi Bio acquired by Merck in multimillion dollar deal

Modifi Bio’s founders discuss the journey from developing a cancer treatment drug to being acquired by Big Pharma.

Connecticut Governor and Comptroller urge Prospect Medical Holdings and YNHH to close $435 million acquisition deal

Officials argue that the deal’s collapse negatively impacts local communities, while two hospital systems battle over the deal in courts.